A Potential Role of MicroRNA in the Renal Cancer and Its Tumor Microenvironment

Renal cell carcinoma (RCC) accounts for approximately 2.2% of all diagnosed cancers and 1.8% of cancer-related deaths. Clear cell renal cell carcinoma (ccRCC) is the most prevalent subtype of RCC, accounting for approximately 70–80% of all cases. Despite significant advancements in therapeutic strat...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel Chikere Ali, Siva Bharath Merugu
Format: Article
Language:English
Published: Asian Medical Press Ltd.(H.K.) 2025-01-01
Series:Annals of Urologic Oncology
Subjects:
Online Access:http://auo.asmepress.com/articles/new-47-601.html
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832581918208557056
author Daniel Chikere Ali
Siva Bharath Merugu
author_facet Daniel Chikere Ali
Siva Bharath Merugu
author_sort Daniel Chikere Ali
collection DOAJ
description Renal cell carcinoma (RCC) accounts for approximately 2.2% of all diagnosed cancers and 1.8% of cancer-related deaths. Clear cell renal cell carcinoma (ccRCC) is the most prevalent subtype of RCC, accounting for approximately 70–80% of all cases. Despite significant advancements in therapeutic strategies over recent decades, treatment outcomes for ccRCC patients remain suboptimal. Prognosis for individuals with advanced or metastatic ccRCC continues to be poor, with a 5-year survival rate below 10%. This is largely due to the intricate and heterogeneous nature of the tumor microenvironment (TME). Current biomarkers and screening techniques for RCC often lack sensitivity or are cost-prohibitive, highlighting the need for novel biomarkers that enable early detection, particularly in high-risk populations. MicroRNAs (miRNAs) exhibit unique properties that make them promising candidates for cancer biomarker development. Researchers have analyzed miRNA expression profiles in biological samples from RCC patients, identifying specific circulatory or urinary miRNAs as potential diagnostic or follow-up markers. Additionally, the expression patterns of certain miRNAs have been linked to patient responses to chemotherapy, immunotherapy, and targeted treatments such as sunitinib. This study reviews existing research on the role of miRNAs in RCC, including their potential as biomarkers, therapeutic targets, and regulators of treatment response in affected patients.
format Article
id doaj-art-c64618035c1a404a9933ca7554d03638
institution Kabale University
issn 2617-7765
2617-7773
language English
publishDate 2025-01-01
publisher Asian Medical Press Ltd.(H.K.)
record_format Article
series Annals of Urologic Oncology
spelling doaj-art-c64618035c1a404a9933ca7554d036382025-01-30T08:28:26ZengAsian Medical Press Ltd.(H.K.)Annals of Urologic Oncology2617-77652617-77732025-01-01810.32948/auo.2025.01.25A Potential Role of MicroRNA in the Renal Cancer and Its Tumor MicroenvironmentDaniel Chikere Ali0Siva Bharath Merugu1Maduka University, School of Pharmacy, Along Nsukka - Enugu New Road, Ekwegbe, Enugu State, Nigeria.Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.Renal cell carcinoma (RCC) accounts for approximately 2.2% of all diagnosed cancers and 1.8% of cancer-related deaths. Clear cell renal cell carcinoma (ccRCC) is the most prevalent subtype of RCC, accounting for approximately 70–80% of all cases. Despite significant advancements in therapeutic strategies over recent decades, treatment outcomes for ccRCC patients remain suboptimal. Prognosis for individuals with advanced or metastatic ccRCC continues to be poor, with a 5-year survival rate below 10%. This is largely due to the intricate and heterogeneous nature of the tumor microenvironment (TME). Current biomarkers and screening techniques for RCC often lack sensitivity or are cost-prohibitive, highlighting the need for novel biomarkers that enable early detection, particularly in high-risk populations. MicroRNAs (miRNAs) exhibit unique properties that make them promising candidates for cancer biomarker development. Researchers have analyzed miRNA expression profiles in biological samples from RCC patients, identifying specific circulatory or urinary miRNAs as potential diagnostic or follow-up markers. Additionally, the expression patterns of certain miRNAs have been linked to patient responses to chemotherapy, immunotherapy, and targeted treatments such as sunitinib. This study reviews existing research on the role of miRNAs in RCC, including their potential as biomarkers, therapeutic targets, and regulators of treatment response in affected patients.http://auo.asmepress.com/articles/new-47-601.htmlmicrornasrenal cell carcinomabiomarkerstumor microenvironment
spellingShingle Daniel Chikere Ali
Siva Bharath Merugu
A Potential Role of MicroRNA in the Renal Cancer and Its Tumor Microenvironment
Annals of Urologic Oncology
micrornas
renal cell carcinoma
biomarkers
tumor microenvironment
title A Potential Role of MicroRNA in the Renal Cancer and Its Tumor Microenvironment
title_full A Potential Role of MicroRNA in the Renal Cancer and Its Tumor Microenvironment
title_fullStr A Potential Role of MicroRNA in the Renal Cancer and Its Tumor Microenvironment
title_full_unstemmed A Potential Role of MicroRNA in the Renal Cancer and Its Tumor Microenvironment
title_short A Potential Role of MicroRNA in the Renal Cancer and Its Tumor Microenvironment
title_sort potential role of microrna in the renal cancer and its tumor microenvironment
topic micrornas
renal cell carcinoma
biomarkers
tumor microenvironment
url http://auo.asmepress.com/articles/new-47-601.html
work_keys_str_mv AT danielchikereali apotentialroleofmicrornaintherenalcanceranditstumormicroenvironment
AT sivabharathmerugu apotentialroleofmicrornaintherenalcanceranditstumormicroenvironment
AT danielchikereali potentialroleofmicrornaintherenalcanceranditstumormicroenvironment
AT sivabharathmerugu potentialroleofmicrornaintherenalcanceranditstumormicroenvironment